Ignite Creation Date:
2025-12-25 @ 2:23 AM
Ignite Modification Date:
2025-12-27 @ 11:21 PM
Study NCT ID:
NCT06324734
Status:
COMPLETED
Last Update Posted:
2025-06-13
First Post:
2024-03-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-04-29
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-15
Completion Date Type:
ACTUAL
First Submit Date:
2024-03-11
First Submit QC Date:
None
Study First Post Date:
2024-03-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-10
Last Update Post Date:
2025-06-13
Last Update Post Date Type:
ACTUAL